Fidia Farmaceutici, S.p.A. Release: Fidia Farmaceutici, S.p.A.'s European Patent on Cross-Linked Gel Slurries Has Been Entirely Revoked by the EPO Board of Appeal

Published: Dec 02, 2008

ABANO TERME, Italy--(BUSINESS WIRE)--Fidia Farmaceutici S.p.A. announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation (Cambridge, MA, USA) has been entirely successful. Indeed, Genzyme's EP patent has been finally revoked in its entirety by the EPO Board of Appeal (decision T 0450/03 of 12 February 2008).

Back to news